Acadian Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,692
| Closed | -$93K | – | 2061 |
|
|
2024
Q3 | $93K | Buy |
+1,692
| New | +$93K | ﹤0.01% | 1614 |
|
|
2023
Q3 | – | Sell |
-1,940
| Closed | -$88K | – | 1804 |
|
|
2023
Q2 | $88K | Sell |
1,940
-8,463
| -81% | -$384K | ﹤0.01% | 1429 |
|
|
2023
Q1 | $416K | Buy |
10,403
+5,437
| +109% | +$217K | ﹤0.01% | 1097 |
|
|
2022
Q4 | $228K | Buy |
4,966
+4,196
| +545% | +$193K | ﹤0.01% | 1249 |
|
|
2022
Q3 | $31K | Buy |
+770
| New | +$31K | ﹤0.01% | 1555 |
|
|
2021
Q3 | – | Sell |
-424
| Closed | -$40K | – | 1962 |
|
|
2021
Q2 | $40K | Buy |
+424
| New | +$40K | ﹤0.01% | 1835 |
|
|
2021
Q1 | – | Sell |
-364
| Closed | -$50K | – | 2279 |
|
|
2020
Q4 | $50K | Buy |
+364
| New | +$50K | ﹤0.01% | 1933 |
|